MichaelDSteinMD

Geriatrics • Riverside, RI

Professor, Medicine, Brown University Program in Medicine

Join to view full profile

Are you Dr. Stein?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 47 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
375 Wampanoag Trl
Suite 301
Riverside, RI 02915
Phone+1 401-649-4050

Fax+1 401-649-4051

Summary

Dr. Michael Stein, MD is a geriatrician in Riverside, Rhode Island. He is currently licensed to practice medicine in Rhode Island and Massachusetts. He is affiliated with Rhode Island Hospital and is a Professor at Brown University Program in Medicine.

Education & Training

Tufts Medical CenterResidency, Internal Medicine, 1985 - 1988
Columbia University Vagelos College of Physicians and SurgeonsClass of 1985

Certifications & Licensure

MA State Medical License 1999 - 2026
RI State Medical License 1988 - 2026
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

Combined PPC-PCMH Program National Committee for Quality Assurance, 2013-2015
CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2011-2013

Clinical Trials

Cognitive Behavioral Therapy Combined With Antidepressants to Reduce HIV Risk and Drug Relapse Among Depressed Intravenous Drug Users Start of enrollment: 1999 Sep 01
Completed
Phase 3
Effectiveness of a Telephone Intervention Program in Improving Depression, Coping, and Family Functioning in HIV-Infected Individuals and Caregivers Start of enrollment: 2000 Sep 01
Completed
Phase 3
A Trial to Reduce Hepatitis C Among Injection Drug Users - 1 Start of enrollment: 2000 Sep 01
Completed
Phase 3
A Brief Marijuana Intervention for Adolescent Women - 1 Start of enrollment: 2004 Sep 01
Completed
Phase 3
Antidepressant Medication for Reducing HIV Risk Behavior in Depressed Intravenous Drug Users Start of enrollment: 2000 Sep 01
Completed
Phase 3
Interactive Voice Response (IVR) for Methadone Patients Start of enrollment: 2006 Jan 01
Completed
Insomnia and Drug Relapse Risk Start of enrollment: 2005 Oct 01
Completed
Phase 3
Motivational Program for Smokers Enrolled in a Methadone Maintenance Program Start of enrollment: 2001 Jun 01
Completed
Not Applicable
SSRI and Buprenorphine Start of enrollment: 2006 Dec 01
Completed
Phase 3
Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking Start of enrollment: 2008 Sep 01
Completed
Not Applicable
Treating Chronic Pain and Depression in HIV+ Patients in Primary Care Settings Start of enrollment: 2012 Nov 01
Completed
Not Applicable
Treating Chronic Pain in Buprenorphine Patients in Primary Care Settings Start of enrollment: 2012 Sep 01
Completed
Not Applicable
Preventing Bacterial and Viral Infections Among Injection Drug Users Start of enrollment: 2013 Sep 01
Completed
Not Applicable
AA Linkage for Alcohol Abusing Women Leaving Jail Start of enrollment: 2013 Oct 01
Completed
Not Applicable
Engaging HIV Patients in Primary Care by Promoting Acceptance Start of enrollment: 2013 Mar 01
Completed
Not Applicable
Treating Comorbid Pain and Depression in HIV+ Individuals Start of enrollment: 2016 Nov 15
Completed
Not Applicable
Join now to see all

Publications & Presentations

PubMed

1 citations
Study protocol for the Treating Opioid Patients' Pain and Sadness (TOPPS) study - A randomized control trial to lower depression and chronic pain interference, and inc...
Michael D Stein, Sally Bendiks, Skylar Karzhevsky, Claire Pierce, Ana Dunn
Contemporary Clinical Trials. 2024-08-01
Risk behaviors among persons civilly committed for opioid use.
Paul P. Christopher, Catherine Stewart, William Manning, Bradley J. Anderson, Alexander Woodruff
Journal of Substance Abuse Treatment. 2022-01-01
6 citations
Retention in care for persons with opioid use disorder transitioning from sublingual to injectable buprenorphine.
Michael D. Stein, Donnell VanNoppen, Debra S. Herman, Bradley J. Anderson, Micah T. Conti
Journal of Substance Abuse Treatment. 2021-11-14

Press Mentions

A Doctor Examines His Profession, and His ChoicesNovember 4th, 2022